期刊文献+

1189例卡前列甲酯栓药品不良反应报告分析 被引量:2

Analysis of 1189 Cases of Adverse Drug Relations Induced by Carboprost Methylate
下载PDF
导出
摘要 目的探讨卡前列甲酯栓不同给药途径下的药品不良反应发生规律及特点,为临床合理用药提供依据。方法对2005~2017年泛珠三角不良反应网络管理平台收集的卡前列甲酯栓药品不良反应/事件报告从患者性别、年龄、既往史、用药原因、给药途径、不良反应发生时间、不良反应表现和不良反应累及系统-器官等进行回顾性分析。结果卡前列甲酯栓药品不良反应多在用药当天发生,药品不良反应累及胃肠系统损害、全身性损害和皮肤及附件损害等,严重不良反应多在用药后半小时出现。结论临床应重视该药的不良反应,特别是严重不良反应,药品生产企业应及时修订完善药品说明书,保障患者用药安全。 Objective To investigate the general characteristics and relative factor of the adverse drug reactions induced by carboprost methylate, so as to provide reference of clinical rational and safe use of drug. Methods By retrospective study method, we analyzed the 1 189 cases of adverse drug relations/events induced by carboprost methylate in the adverse reaction network platform of Pan-Pearl River Delta from 2005 to 2017. By retrospective study method, we analyzed the patient's age, gender, past history, the purpose of drug use,occurrence time, symptoms of adverse drug reactions, the system involved etc. Results The adverse drug reactions of carboprost methylate mainly occurred on the day of medication. The systems involved of adverse drug reactions include the gastrointestinal system damage, systemic damage,skin and its accessories damage etc.Serious adverse drug reactions mostly occurred in half an hour after the drug use. Conclusion Clinic should pay attention to the drug adverse reactions of carboprost methylate, especially to the serious adverse reactions.Drug manufacturers should promptly revise and improve the safety information of drug instructions,so as to ensure the safety of drug use.
作者 张纾 林强 邓文 陈深 ZHANG Shu;LIN Qiang;DENG Wen;CHEN Shen(Center for ADR Monitoring of Fujian,Fujian Fuzhou350002,China;Fuzhou Medical Security Fund Management Center,Fujian Fuzhou 350005,China;Center forADR Monitoring of Fuzhou,Fujian Fuzhou 350014,China)
出处 《中国药物警戒》 2019年第6期374-378,380,共6页 Chinese Journal of Pharmacovigilance
关键词 卡前列甲酯栓 药品不良反应 合理用药 carboprost methylate adverse drug reaction rational use of drug
  • 相关文献

参考文献12

二级参考文献103

  • 1武志昂,毕开顺.刍议企业在药品上市后风险管理中的责任[J].中国药物警戒,2007,4(2):65-67. 被引量:12
  • 2刘彩霞,王德智,李秀芹,杨玉侠,张健,兰涛.卡前列甲酯栓预防产后出血的临床研究[J].中华妇产科杂志,1997,32(1):22-24. 被引量:169
  • 3卫生部,国家食品药品监督管理局.药品不良反应报告和监测管理办法[EB/OL]http://www.sda.gov.cn/WS01/CL0053/24477.html.2010-06-02.
  • 4Tang OS,Schweer H,Seyberth HW,et al.Pharmacokinetics of different routes of administration of misoprostol.Hum Reprod,2002,17(2):332-336
  • 5Bygdeman M.Pharmacokinetics of prostaglandins.Best Pract Res Clin Obstet Gynaecol,2003,17(5):707-716
  • 6Aronsson A,Bygdeman M,Gemzell-Danielsson K.Effects of misoprostol on uterine contractility following different routes of administration.Hum Reprod,2004,19(1):81-84
  • 7Vimala N,Mittal S,Kumar S,et al.A randomized comparison of sublingual and vaginal misoprostol for cervical priming before suction termination of first-trimester pregnancy.Contraception,2004,70(2):117-120
  • 8陈易新,田春华.从药品不良反应信息通报品种看药品风险管理(一)[J].中国药物警戒,2007,4(5):257-260. 被引量:14
  • 9Soyer P,Morel O,Fargeaudou Y. Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta,increta or percreta[J].European Journal of Radiology,2011,(03):729-735.
  • 10Wang CJ,Yang NH,Liou SH. Fast quantification of the exhaled breath condensate of oxidative stress 8-iso-prostaglandin F2α using on-line solid-phase extraction coupled with liquid chromatography/electrospray ionization mass spectrometry[J].{H}TALANTA,2010,(04):1434-1438.

共引文献118

同被引文献11

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部